Literature DB >> 26458492

Expression of glycoprotein nonmetastatic melanoma protein B in macrophages infiltrating injured mucosa is associated with the severity of experimental colitis in mice.

Fumisato Sasaki1, Kotaro Kumagai1, Hirofumi Uto1, Yoichiro Takami2, Takeshi Kure1, Kazuaki Tabu1, Yuichro Nasu1, Shinichi Hashimoto1, Shuji Kanmura1, Masatsugu Numata1, Akihiro Moriuchi3, Toshio Sakiyama1, Hirohito Tsubouchi3, Akio Ido1.   

Abstract

Glycoprotein nonmetastatic melanoma protein B (Gpnmb) is a transmembrane glycoprotein, which negatively regulates the inflammatory responses of macrophages. However, the role of Gpnmb in intestinal macrophages remains to be fully elucidated. The present study aimed to investigate the expression of Gpnmb and its effects on colonic mucosal injuries associated with dextran sulfate sodium (DSS)‑induced colitis in BALB/c mice, DBA/2J (D2) mice lacking Gpnmb and Gpnmb‑transgenic DBA/2J mice (D2‑gpnmb+). The colonic expression of Gpnmb increased with the severity of DSS‑induced colitis in BALB/c mice, and macrophages infiltrating the inflamed mucosa were found to express Gpnmb. The D2 mice lacking Gpnmb exhibited more severe DSS‑induced colitis, which was accompanied by higher levels of pro‑inflammatory cytokines, including interleukin (IL)‑1β and IL‑6, compared with the D2‑gpnmb+ mice. Following lipopolysaccharide stimulation, macrophages from the D2 mice expressed higher levels of pro‑inflammatory cytokines and lower levels of IL‑10, compared with the D2‑gpnmb+mice. In addition, in the RAW264.7 murine macrophage cell line, knockdown of Gpnmb by small interfering RNA was associated with increased production of pro‑inflammatory cytokines, which were potentially mediated by the extracellular signal‑regulated kinase (ERK) and p38 signaling pathways. The results of the present study indicated that macrophages infiltrating injured mucosa express Gpnmb, and that Gpnmb‑positive macrophages may ameliorate inflammation in the intestinal mucosa by decreasing pro‑inflammatory cytokine production via the ERK and p38 signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26458492     DOI: 10.3892/mmr.2015.4408

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

Review 1.  Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  FASEB J       Date:  2020-05-23       Impact factor: 5.191

Review 2.  GPNMB: a potent inducer of immunosuppression in cancer.

Authors:  Anna-Maria Lazaratos; Matthew G Annis; Peter M Siegel
Journal:  Oncogene       Date:  2022-09-01       Impact factor: 8.756

3.  Loss of GPNMB Causes Autosomal-Recessive Amyloidosis Cutis Dyschromica in Humans.

Authors:  Chi-Fan Yang; Shuan-Pei Lin; Chien-Ping Chiang; Yu-Hung Wu; Weng Siong H'ng; Chun-Ping Chang; Yuan-Tsong Chen; Jer-Yuarn Wu
Journal:  Am J Hum Genet       Date:  2018-01-11       Impact factor: 11.025

4.  The STAT3-IL-10-IL-6 Pathway Is a Novel Regulator of Macrophage Efferocytosis and Phenotypic Conversion in Sterile Liver Injury.

Authors:  Lara Campana; Philip J Starkey Lewis; Antonella Pellicoro; Rebecca L Aucott; Janet Man; Eoghan O'Duibhir; Sarah E Mok; Sofia Ferreira-Gonzalez; Eilidh Livingstone; Stephen N Greenhalgh; Katherine L Hull; Timothy J Kendall; Douglas Vernimmen; Neil C Henderson; Luke Boulter; Christopher D Gregory; Yi Feng; Stephen M Anderton; Stuart J Forbes; John P Iredale
Journal:  J Immunol       Date:  2017-12-20       Impact factor: 5.422

Review 5.  The Role of GPNMB in Inflammation.

Authors:  Marina Saade; Giovanna Araujo de Souza; Cristoforo Scavone; Paula Fernanda Kinoshita
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

6.  Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson's disease on chromosome 7p15.3.

Authors:  Megha N Murthy; Cornelis Blauwendraat; Sebastian Guelfi; John Hardy; Patrick A Lewis; Daniah Trabzuni
Journal:  Neurogenetics       Date:  2017-04-08       Impact factor: 2.660

7.  Association Between Factors Involved in Bone Remodeling (Osteoactivin and OPG) With Plasma Levels of Irisin and Meteorin-Like Protein in People With T2D and Obesity.

Authors:  Preethi Cherian; Irina Al-Khairi; Mohammad Jamal; Suleiman Al-Sabah; Hamad Ali; Carol Dsouza; Eman Alshawaf; Waleed Al-Ali; Ghanim Al-Khaledi; Fahd Al-Mulla; Mohamed Abu-Farha; Jehad Abubaker
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-29       Impact factor: 5.555

Review 8.  A new hypothesis for Parkinson's disease pathogenesis: GTPase-p38 MAPK signaling and autophagy as convergence points of etiology and genomics.

Authors:  Julia Obergasteiger; Giulia Frapporti; Peter P Pramstaller; Andrew A Hicks; Mattia Volta
Journal:  Mol Neurodegener       Date:  2018-08-02       Impact factor: 14.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.